Generative Bionics partners with Fincantieri on humanoid welding robot for shipyards

Generative Bionics partners with Fincantieri on humanoid welding robot for shipyards

Generative Bionics and Fincantieri have launched a four-year industrial collaboration to develop an autonomous humanoid welding robot for shipyard environments, with development and testing centred at Fincantieri's Sestri Ponente shipyard in Genoa.

Generative Bionics was founded in July 2024 in Genoa as a spinoff of the Italian Institute of Technology. It is the largest spinoff in IIT's history and one of the largest research spinoffs in Europe. The founding team is drawn entirely from IIT: Daniele Pucci as CEO, Alessio Del Bue as Chief Artificial Intelligence Officer, Marco Maggiali as Chief Technology Officer, and Andrea Pagnin as Chief Business Officer, joined by Executive Chairman Davide Rota and co-founder Jeffrey Libshutz. Approximately 70 engineers from IIT transferred into the company's technical division at founding, supported by specialists in certification, industrialisation, and production of humanoid systems.

The research foundation behind Generative Bionics spans twenty years and three distinct IIT robot programs, each of which contributed specific technology to what became the company's platform. iCub, IIT's cognitive research robot, contributed the distributed network of tactile and force sensors that enables safe physical interaction. ergoCub, a humanoid co-developed with INAIL, Italy's national workers' compensation authority, contributed the Physical AI architecture that allows humanoids to be configured for specific applications and to learn directly from real environments. iRonCub, the world's only flying humanoid robot, contributed advanced AI methods for adaptation to extreme operational conditions including high temperatures and complex outdoor environments. More than 60 humanoid prototypes were designed, tested, and refined at IIT over this period, many of which were provided as research platforms to robotics centres worldwide.

Generative Bionics closed a €70 million round in December 2025, led by the Artificial Intelligence Fund of CDP Venture Capital, with participation from AMD Ventures, Duferco, Eni Next, RoboIT, and Tether. The investor composition is worth reading as a structure. CDP Venture Capital is Italy's state-backed venture investor and had been involved since the prototyping phase through the RoboIT technology transfer hub. Duferco is an Italian industrial and steel group; Eni Next is the innovation and energy transition arm of Eni. The round is as much an Italian industrial policy vehicle as a market-rate financing, which is consistent with the company's positioning as a European sovereign alternative in humanoid robotics.

In January 2026, at the AMD opening keynote at CES, AMD Chair and CEO Lisa Su hosted Daniele Pucci to unveil GENE.01, the company's first complete humanoid concept. GENE.01 features a full-body tactile skin, a distributed network of touch and force sensors, and runs on AMD's high-performance computing and FPGA-based embedded vision platforms, treating the robot's own body as part of the compute infrastructure for real-time environmental adaptation.

The Fincantieri collaboration is built around a specific strategic design decision Pucci has stated explicitly: GENE.01 is not intended as a general-purpose robot but as a configurable base platform from which industry-specific humanoids are derived. A humanoid welding inside a shipyard operates in a fundamentally different environment from one assisting a patient in a hospital; the safety requirements, operational constraints, and certification pathways are not the same. The Fincantieri partnership produces the first named derivative: GENE.01/W, optimised for welding applications in naval prefabrication. The target environment is shipyard hull assembly, where constrained geometries, high temperatures, and physically demanding repetitive work create both safety risk and skilled-labour pressure.

Initial on-site tests at Sestri Ponente are scheduled by the end of 2026; the objective is to make operational functionality available within the first two years of the programme, followed by refinement, expansion, and industrial certification activities thereafter. No commercial deployment or production volume has been disclosed. Generative Bionics is in the development and industrial validation phase; the Fincantieri programme is the first named deployment environment, not evidence of broader commercial rollout.

Have a robotics update Korthos should review? Send news, deployments, product releases, funding rounds, research, or media to tips@korthos.xyz or reach out on X at @agkorthos.